Amphastar Pharmaceuticals, Inc. (AMPH) financial statements and ratios from SEC XBRL: revenue $0.7B (TTM), net margin 13.6%, revenue growth -1.7% YoY, P/E 15.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $719.89M |
| Revenue (TTM) | $0.7B |
| Net Margin | 13.6% |
| Operating Margin (TTM) | 12.4% |
| Revenue Growth (YoY) | -1.7% |
| EPS Growth (YoY) | -36.2% |
| FCF Growth (YoY) | -29.7% |
| P/E Ratio | 15.7 |
| EV / EBITDA | 5.3 |
| Price / Book | 1.24 |
| Price / Sales | 1.33 |
| FCF Yield | 26.7% |
| Altman Z-Score | 2.35 (grey) |
| Piotroski F-Score | 6/9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
AMPH overview · AMPH earnings · AMPH KPIs · AMPH documents · AMPH ownership · AMPH peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.